![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Glenmark Starts Revamilast Phase IIb Trials
Glenmark Starts Revamilast Phase IIb Trials
August 11, 2011
Indian drugmaker Glenmark Pharmaceuticals has started Phase IIb trials to evaluate Revamilast as a treatment for inflammatory disorders like rheumatoid arthritis and asthma.
PBR
PBR
Upcoming Events
-
21Oct